Merck & Co., Inc. (NYSE:MRK) Price Target Cut to $110.00 by Analysts at Wells Fargo & Company
Merck & Co., Inc. (NYSE:MRK – Free Report) had its price target cut by Wells Fargo & Company from $125.00 to $110.00 in a research note issued to investors on Friday morning, Benzinga reports. They currently have an equal weight rating on the stock. Other equities analysts also recently issued reports about the stock. Evercore […]
2 Nov 16:45 · The Markets Daily